Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|September 6, 2017
Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and CancerAudrey Aussy, Olivier Boyer, Nadège Cordel
Drug Discovery Today|July 5, 2021
IFN-α: A key therapeutic target for multiple autoimmune rheumatic diseasesFrédéric De Ceuninck, Fanny Duguet, Audrey Aussy, et al.
Expert Review of Clinical Immunology|November 29, 2021
Model-based computational precision medicine to develop combination therapies for autoimmune diseasesEmiko Desvaux, Audrey Aussy, Sandra Hubert, et al.
Expert Opinion on Drug Discovery|July 5, 2022
Industrializing AI-powered drug discovery: lessons learned from the Patrimony computing platformMickaël Guedj, Jack Swindle, Antoine Hamon, et al.
Plos One|July 22, 2021
Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19Emiko Desvaux, Antoine Hamon, Sandra Hubert, et al.
Iscience|February 10, 2025
Virtual patients inspired by multiomics predict the efficacy of an anti-IFNα mAb in cutaneous lupusVincent Hurez, Glenn Gauderat, Perrine Soret, et al.
The FEBS Journal|July 7, 2025
Multi-omic analysis identifies biological processes underlying progressive interstitial lung disease in systemic sclerosisSelena Bouffette, Perrine Soret, Alice Cole, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2019
The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult DermatomyositisAudrey Aussy, Manuel Fréret, Laure Gallay, et al.
Clinical Immunology (Orlando, Fla.)|May 12, 2024
Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's diseaseCheïma Boudjeniba, Perrine Soret, Diana Trutschel, et al.
Pageof 1